EDIL3 and VEGF Synergistically Affect Angiogenesis in Endothelial Cells

References

• Lebwohl M. Psoriasis. Ann Intern Med. 2018;168(7):ITC49–ITC64. doi:10.7326/AITC201804030
   PubMed Web of Science ®Google Scholar
• Akhtar T, Wani WY, Kamal MA, et al. Role of angiogenic growth factors in psoriasis: a review. Curr Drug Metab. 2018;19(11):910–916. doi:10.2174/1389200219666180416162942
   PubMed Web of Science ®Google Scholar
• Mousavi SA, Skjeldal F, Fønhus MS, et al. Receptor-mediated endocytosis of VEGF-A in rat liver sinusoidal endothelial cells. Biomed Res Int. 2019;2019:599–619. doi:10.1155/2019/5496197
   Web of Science ®Google Scholar
• Li T, Gu M, Liu P, et al. Clinical significance of decreased interleukin-35 expression in patients with psoriasis. Microbiol Immunol. 2018;62:454–461.
   Web of Science ®Google Scholar
• Chen W, Wu L, Zhu W, et al. The polymorphisms of growth factor genes (VEGFA & EGF) were associated with response to Acitretin in psoriasis. Per Med. 2018;15(3):181–188. doi:10.2217/pme-2017-0085
   PubMed Web of Science ®Google Scholar
• Glazewska EK, Niczyporuk M, Lawicki S, et al. ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients. Postepy Dermatol Alergol. 2018;35(2):167–173. doi:10.5114/pdia.2017.66621
   PubMed Web of Science ®Google Scholar
• Yu AR, Hao P, Hao S, et al. MiR-876–5p suppresses cell proliferation by targeting angiopoietin-1 in the psoriasis. Biomed Pharmacother. 2018;103:1163–1169. doi:10.1016/j.biopha.2018.04.145
   PubMed Web of Science ®Google Scholar
• Khandia R, Munjal A, Dhama K, et al. Bacterial toxins: a hope toward angiogenic ailments. Curr Drug Metab. 2017;18(10):926–941. doi:10.2174/1389200218666170911150948
   PubMed Web of Science ®Google Scholar
• Mehta NN, Shin DB, Joshi AA, et al. Effect of psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: a randomized placebo-controlled trial. Circ Cardiovasc Imaging. 2018;11(6):e007394. doi:10.1161/CIRCIMAGING.117.007394
   PubMed Web of Science ®Google Scholar
• Li S, Xu HX, Wu CT, et al. Angiogenesis in pancreatic cancer: current research status and clinical implications. Angiogenesis. 2019;22(1):15–36. doi:10.1007/s10456-018-9645-2
   PubMed Web of Science ®Google Scholar
• Schröder K. Redox control of angiogenesis. Antioxid Redox Signal. 2019;30(7):960–971. doi:10.1089/ars.2017.7429
   PubMed Web of Science ®Google Scholar
• Luengas-Martinez A, Hardman-Smart J, Rutkowski D, et al. Vascular endothelial growth factor blockade induces dermal endothelial cell apoptosis in a clinically relevant skin organ culture model. Skin Pharmacol Physiol. 2020;33(3):110–118. doi:10.1159/000508344
   PubMed Web of Science ®Google Scholar
• Kuang YH, Lu Y, Liu YK, et al. Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes. Eur J Pharmacol. 2018;824:57–63. doi:10.1016/j.ejphar.2018.01.048
   PubMed Web of Science ®Google Scholar
• Patel AB, Tsilioni I, Weng Z, et al. TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin. Exp Dermatol. 2018;2(2):135–143. doi:10.1111/exd.13461
   Google Scholar
• Chung SW, Bae SM, Lee M, et al. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways. Biomaterials. 2015;37:271–278. doi:10.1016/j.biomaterials.2014.10.004
   PubMed Web of Science ®Google Scholar
• Lin QH, Qu W, Xu J, et al. 1-methoxycarbonyl-β-carboline from picrasma quassioides exerts antiangiogenic properties in HUVECs in vitro and zebrafish embryos in vivo. Chin J Nat Med. 2018;16(8):599–609. doi:10.1016/S1875-5364(18)30097-9
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lee J, Kim WW, et al. Del-1 expression as a potential biomarker in triple-negative early breast cancer. Oncology. 2018;94(4):243–256. doi:10.1159/000485658
   PubMed Web of Science ®Google Scholar
• Yan S, Chen L, Zhao Q, et al. Developmental endothelial locus-1 (Del-1) antagonizes interleukin-17-mediated allergic asthma. Immunol Cell Biol. 2018;96(5):526–535. doi:10.1111/imcb.12023
   PubMed Web of Science ®Google Scholar
• Schürpf T, Chen Q, Liu JH, et al. The RGD finger of Del-1 is a unique structural feature critical for integrin binding. FASEB J. 2012;26(8):3412–3420. doi:10.1096/fj.11-202036
   PubMed Web of Science ®Google Scholar
• Jeong D, Ban S, Oh S, et al. Prognostic significance of edil3 expression and correlation with mesenchymal phenotype and microvessel density in lung adenocarcinoma. Sci Rep. 2017;2017(1):8649.
   Google Scholar
• Lee J, Jeong JH, Jung JH, et al. Overcoming tamoxifen resistance by regulation of Del-1 in breast cancer. Oncology. 2019;97(3):180–188. doi:10.1159/000501340
   PubMed Web of Science ®Google Scholar
• Folwaczny M, Karnesi E, Berger T, et al. Clinical association between chronic periodontitis and the leukocyte extravasation inhibitors developmental endothelial locus-1 and pentraxin-3. Eur J Oral Sci. 2017;125(4):258–264. doi:10.1111/eos.12357
   PubMed Web of Science ®Google Scholar
• Niu X, Chang W, Liu R, et al. mRNA and protein expression of the angiogenesis-related genes EDIL3, AMOT and ECM1 in mesenchymal stem cells in psoriatic dermis. Clin Exp Dermatol. 2016;41(5):533–540. doi:10.1111/ced.12783
   PubMed Web of Science ®Google Scholar
• MacDonald A, Burden AD. Psoriasis: advances in pathophysiology and management. Postgrad Med J. 2007;83:690–697. doi:10.1136/pgmj.2007.061473
   PubMed Web of Science ®Google Scholar
• Costa C, Soares R, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis. 2007;10:149–166. doi:10.1007/s10456-007-9074-0
   PubMedGoogle Scholar
• Fan Y, Zhu W, Yang M, et al. Del-1 gene transfer induces cerebral angiogenesis in mice. Brain Res. 2008;1219:1–7. doi:10.1016/j.brainres.2008.05.003
   PubMed Web of Science ®Google Scholar
• Anne Klotzsche-von A, Cremer S, Hoffmann J, et al. Endogenous developmental endothelial locus-1 limits ischaemia-related angiogenesis by blocking inflammation. Thromb Haemost. 2017;117(6):1150–1163. doi:10.1160/TH16-05-0354
   PubMed Web of Science ®Google Scholar
• Creamer D, Sullivan D, Bicknell R, et al. Angiogenesis in psoriasis. Angiogenesis. 2002;5(4):231–236. doi:10.1023/A:1024515517623
   PubMedGoogle Scholar
• Orciani M, Campanati A, Salvolini E, et al. The mesenchymal stem cell profile in psoriasis. Br J Dermatol. 2011;165(3):585–592. doi:10.1111/j.1365-2133.2011.10438.x
   PubMed Web of Science ®Google Scholar
• Hou R, Yin G, Peng A, et al. DNA methylation of dermal MSCs in psoriasis: identification of epigenetically dysregulated genes. J Dermatol Sci. 2013;72(2):103–109. doi:10.1016/j.jdermsci.2013.07.002
   PubMed Web of Science ®Google Scholar
• Creamer D, Allen M, Sousa A, et al. Altered vascular endothelium integrin expression in psoriasis. Am J Pathol. 1995;147(6):1661–1667.
   PubMed Web of Science ®Google Scholar
• Zhong J, Eliceiri B, Stupack D, et al. Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J Clin Invest. 2003;112(1):30–41. doi:10.1172/JCI17034
   PubMed Web of Science ®Google Scholar
• Kun Z, Xin G, Tao W, et al. Tumor derived EDIL3 modulates the expansion and osteoclastogenesis of myeloid derived suppressor cells in murine breast cancer model. J Bone Oncol. 2019;16:100–138. doi:10.1016/j.jbo.2019.100238
   Web of Science ®Google Scholar